Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats

Hypertension

Volumn 27, Issue 1, 1996, Pages 14-18

  Matsuoka, Hidehiro ^a   Nakata, Masashi ^a   Kohno, Keisuke ^a   Koga, Yoshinori ^a   Nomura, Gakuji ^a   Toshima, Hironori ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

arginine; cyclic GMP; heart hypertrophy; nitrates; nitric oxide; actin

Indexed keywords

ALPHA ACTIN; ARGININE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; NITRATE; NITRIC OXIDE; NITRITE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART HYPERTROPHY; HEART WEIGHT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE;

EID: 0030059793     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.1.14     Document Type: Article

References (31)

1. Frohlich ED. Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hypertrophy. J Mol Cell Cardiol. 1989;21(suppl V):3-10.
2. Gray SD. Spontaneous hypertension in the neonatal rat: a review. Clin Exp Hypertens. 1984;A6:755-781.
3. Tarazi RC, Sen S. Renin and cardiac hypertrophy. Clin Res. 1972;20:772. Abstract.
4. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
5. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease. Circ Res. 1993;73:217-222.
6. Lincoln TM, Komalavilas P, Cornwell TL. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension. 1994;23(part 2):1141-1147.
7. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
8. Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res. 1995;76:305-309.
9. Smith JA, Shah AM, Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol. 1991;439:1-14.
10. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
11. 2+ -independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
12. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
13. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91:2314-2319.
14. Hasegawa T, Takagi S, Nishimaki K, Morita K, Nakajima S. Impairment of L-arginine metabolism in spontaneously hypertensive rats. Biochem Int. 1992;26:653-658.
15. Kuo JF, Davis CW, Tse J. Depressed cardiac cyclic GMP-dependent protein kinase in spontaneously hypertensive rats and its further depression by guanethidine. Nature. 1976;261:335-336.
16. Lüscher TF, Haefeli WE. L-Arginine in the clinical arena: tool or remedy? Circulation. 1993;87:1746-1748.
17. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension. 1994;23(part 2):971-975.
18. 1-adrenoreceptor-mediated hypertrophy of rat cardiac myocytes. J Clin Invest. 1987;80:1194-1199.
19. Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
20. Izumo S, Nadal-Ginard B, Mahadavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A. 1988;85:339-343.
21. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R. L-Arginine induced hypotension. Lancet. 1990;336:696.
22. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
23. Stier CT Jr, Sim GJ, Levine S. Dietary arginine fails to protect against cerebrovascular damage in stroke-prone hypertensive rats. Brain Res. 1991;549:354-356.
24. Tobian L, Hanlon S. High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension. 1990;15:900-903.
25. Harding P, Carretero OA, LaPointe MC. Effects of interleukin-1β and nitric oxide on cardiac myocytes. Hypertension. 1995;25:421-430.
26. Rhaleb NE, Yang XP, Scicli G, Carretero OA. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension. 1994;23(part 2):865-868.
27. Arnal JF, El Amrani AI, Chatellier G, Ménard J, Michel JB. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
28. Arnal JF, Battle T, Ménard J, Michel JB. The vasodilatory effect of endogenous nitric oxide is a major Counter-regulatory mechanism in the spontaneously hypertensive rat. J Hypertens. 1993;11:945-950.
29. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res. 1992;70:607-611.
30. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius. Circ Res. 1993;72:511-516.
31. Sigmon DH, Carretero OA, Beierwaltes WH. Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol. 1992;263:F256-F261.